Launch Readiness

Launch Readiness

Creating a Successful Drug Commercialization Strategy

Learn how Integrichain helps pharma manufacturing companies develop a strong drug commercialization and launch strategy that addresses market access challenges from the start.

The idea of having a unified platform through a single vendor was so important to us leading up to launch.

Senior Vice President | Finance

Reduce Risk and Time to Launch with a Proven, Comprehensive Drug Commercialization Platform

Manufacturers that successfully implement a well-defined drug commercialization and launch plan are more likely to attain their revenue goals and outperform the competition in their go-to-market strategy. Pre-commercial manufacturers in particular have the unique opportunity to place the patient at the center of their commercial strategy using coordinated, intelligent engagement with guidance from our professional service teams.

Having supported more than 70% of new life science product launches in the US over the past three years, we know the formula:

insights

Pre-launch insights into competitive market baskets, pricing and contracting scenarios, and financial modeling guide the path to launch

channel

Government pricing compliance and commercial contracts are in place and maximized for value

contracts

Data-Driven Gross-to-Net systems are prepared for modeling and forecasting

forecasting

Channel is developed and ready to maintain access to product

journey

Patient access roadblocks are defined, with solutions for resolution

The 5 key factors to a successful pharmaceutical launch

ICyte for Launch Readiness

IntegriChain’s ICyte platform and advisory services help solve these launch readiness challenges with a fully-integrated and scalable approach. New and emerging life science manufacturers will benefit from our launch readiness solutions with a faster, smoother drug commercialization process.

Drug Commercialization Challenges Include:

  • Ensuring processes are in place for day launch
  • Making sure your contracts and pricing are set
  • Verifying that you can accurately monitor your retail and/or specialty channels to assure your product gets to your patients
  • Knowing your financial processes are in place for accurate forecasting and accruals

 

Learn more about ICyte

be prepared day one

Be Prepared for Launch

We are experts in launch readiness.

We deliver expert advisory services on pricing, contracts, and gross-to-net combined with data, analytics, and managed services that adapt to changing demands across your brand’s life cycle.

Our launch readiness services feature:

  • A single partner to manage all your access-related operations
  • World-class, data-driven analytics for strategic market access decision-making
  • Rapid deployment of right-sized solutions with minimal disruption on your team
  • Insights to improve your patient initiation and adherence success
adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand